Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Version / remarks:
- adapted by the Council on 27th July 1995
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- 2,2`-[6-(phenylamino)-1,3,5-triazine-2,4-diyl]diphenol
- Cas Number:
- 1248-66-4
- Molecular formula:
- C21H16N4O2
- IUPAC Name:
- 2,2`-[6-(phenylamino)-1,3,5-triazine-2,4-diyl]diphenol
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories Ltd. Laboratory Animal Services Wölferstrasse 4 4414 Füllinsdorf / Switzerland
- Age at study initiation: (P) 11 weeks
- Weight at study initiation: (P) Males: 298 to 357 g; Females: 186 to 217 g
- Housing: Individually in Makrolon type-3 cages. During the pre-pairing period, cages with males
were interspersed amongst those holding females to promote the development of regular estrus cycles.
- Diet: ad libitum. Pelleted standard Kliba Nafag 3433 rodent maintenance diet (Provimi Kliba SA, 4303 Kaiseraugst / Switzerland).
- Water: ad libitum. Community tap-water from Füllinsdorf.
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3 °C
- Humidity (%): 30 - 70%
- Air changes (per hr): 10 - 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12-hour fluorescent light / 12-hour dark cycle with music during the light period
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 300
- Details on exposure:
- The dose formulations were prepared weekly; addition of 80% PEG 300 to the substance and homogenized; dose volume of 5 ml/kg body weight with daily adjustment to the actual body weight;
- Details on mating procedure:
- - M/F ratio per cage: 1/1
- Length of cohabitation: 14 d
- Proof of pregnancy: [vaginal plug / sperm in vaginal smear] referred to as day 0 of pregnancy - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- HPLC/UV-detection
- Duration of treatment / exposure:
- mailes: 14-day pre-pairing period, pairing period + 1 day; minimum 4 weeks
females: 14-day pre-pairing period, pairing period, gestation, lactation period up to day 4 post partum; approximately 7 weeks; - Frequency of treatment:
- once daily orally by gavage
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
50 mg/kg body weight/day
Basis:
actual ingested
- Remarks:
- Doses / Concentrations:
200 mg/kg body weight/day
Basis:
actual ingested
- Remarks:
- Doses / Concentrations:
1000 mg/kg body weight/day
Basis:
actual ingested
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: The dose levels were selected based on a previous short term study (RCC No. B31972) performed at Harlan Laboratories Ltd. (former RCC Ltd).
- Rationale for animal assignment (if not random):
- Fasting period before blood sampling for clinical biochemistry:
- Other:
Examinations
- Parental animals: Observations and examinations:
- DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: once daily;
BODY WEIGHT: Yes
- Time schedule for examinations: daily
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes - Sperm parameters (parental animals):
- The testes and epididymides of all parental males were weighed as pairs. In addition, adrenal glands and thymus were weighed in males.
- Litter observations:
- PARAMETERS EXAMINED
The following parameters were examined in F1 offspring:
external examination at first Litter Check and a last litter check (day 4); clinical signs and macroscopic findings; number and sex of pups, stillbirths, live births, postnatal mortality, weight gain to day 4 post partum; - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All animals after pairing period
- Maternal animals: All animals on day 4 post partum - Statistics:
- The following statistical methods were used to analyze food consumption, body weights and reproduction data:
• Means and standard deviations of various data were calculated.
• The Dunnett-test (many to one t-test) based on a pooled variance estimate was applied if the variables could be assumed to follow a normal distribution for the comparison of the treated groups and the control groups for each sex.
• The Steel-test (many-one rank test) was applied instead of the Dunnett-test when the data could not be assumed to follow a normal distribution.
• Fisher's exact-test was applied to the macroscopical findings.
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- clinical signs considered to be incidental
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- adrenocortical changes consisting of minimal hypertrophic changes of the zona fasciculate at 200 mg/kg/day ; at 200 and 1000 mg/kg/day, erythropoiesis at minimal degree was noted in two females in each group.
- Other effects:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Details on results (P0)
All animals survived
BODY WEIGHT AND FOOD CONSUMPTION (PARENTAL ANIMALS):
At all dose-levels, there were no treatment-related effects;
REPRODUCTIVE Data (PARENTAL ANIMALS):
At all dose-levels, there were no treatment-related effects on precoital time, mean duration of gestation, number of corpora lutea and implantaions, post-implantation loss, pup survival or litter size from birth through to scheduled sacrifice an day 4 post partum;
ORGAN WEIGHTS (PARENTAL ANIMALS)
No test item related changes were noted in mean organ weight of thymus, adrenals, testes and epididymides in males;
In males and females at 200 mg/kg/day and in females at 1000 mg/kg/day, adrenocortical changes consisting of minimal to moderate hypertrophic changes of the zona fasciculate were noted.
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: with respect to reproduction/ developement toxicity;
- Dose descriptor:
- NOEL
- Effect level:
- 50 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: based on the higher locomotor activity;
- Dose descriptor:
- NOEL
- Effect level:
- 50 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- other: based on erithropoieseis noted during the histopathology examination;
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- effects observed, non-treatment-related
- Histopathological findings:
- effects observed, non-treatment-related
Details on results (F1)
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: fetal toxicity
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- NOEL (reproduction/developmental toxicity) = 1000 mg/kg bw/day
- Executive summary:
The reproductive toxicity of the substance was evaluated in an experimental study performed according to the OECD Guideline 421.
Test item was administered in Milli-Q-Water as vehicle at dosages of 50, 200, and 1000 mg/kg body weight/day, and controls received the vehicle only. Test item was administered to male rats for at least 28 days and to female rats for 15 days prior to pairing, through the pairing and gestation periods until the F1 generation reached day 4 post partum.
All animals survived until the scheduled necropsy and no test item-related clinical signs were noted during the study. Food consumption and body weight were not affected by the treatment with the test item. At 1000 mg/kg/day locomotor activity resulted to be increased in males.
The reproduction and developmental parameters investigated did not give any indication of any
test item-related effects. The weight of thymus, adrenals, testes and epididymides were not affected by the treatment with the test item. At histopathology examination, an increased erythropoiesis was noted in females at 200 and 1000 mg/kg/day.Based on the increased locomotor activity in males and on the increased erithropoiesis in females, the general NOEL (No Observed Effect Level) was considered to be 50 mg/kg body weight/day.
Under the conditions of this study, the NOAEL (No Observed Effect Level) for reproduction/developmental toxicity was considered to be 1000 mg/kg/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.